AMG-691
- Generic Name
- AMG-691
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2025-01-23
- Lead Sponsor
- Amgen
- Target Recruit Count
- 124
- Registration Number
- NCT06637371
- Locations
- 🇺🇸
Orange County Research Center, Lake Forest, California, United States
🇺🇸Translational Clinical Research LLC, Aventura, Florida, United States
🇺🇸Prism Research LLC dba Nucleus Network, Saint Paul, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath